Clinical Trial Update: Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) for Stage II prostate cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: NRG Oncology | Conditions: Stage II Prostate Adenocarcinoma AJCC v7 | Phase 3 | Status: ACTIVE_NOT_RECRUITING